Literature DB >> 20200989

Preventing metastases to bone: denosumab or bisphosphonates?

Mark S Nanes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20200989     DOI： 10.1002/jbmr.71

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  1 in total

1.  Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials.

Authors:  Amr Menshawy; Omar Mattar; Ali Abdulkarim; Shiref Kasem; Noha Nasreldin; Esraa Menshawy; Salahuddean Mohammed; Mohamed Abdel-Maboud; Mohamed Gadelkarim; Gehad Gamal El Ashal; Ahmed Saber Elgebaly
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.